TREATMENTS &
RESEARCH

Search the
latest
treatment
information
here.

Dr. Huntley's
Diagnosis
Checklist

Have a symptom?
See what questions
a doctor would ask.
 

Do not dramatically lower the bloodpressure in patients with increased intracranial pressure (ICP)

Author: Emily Riehm Meier, MD

What to Do - Make a Decision

Brain parenchyma, cerebrospinal fluid (CSF), and blood are the three components of the intracranial cavity (Table 215.1). The durability of the skull protects the brain from outside insults, but cannot accommodate an increase in the amount of intracranial contents. Increased ICP is, therefore, a medical emergency that requires careful diagnosis, monitoring, and management.

The Cushing triad is classically associated with increased ICP but is a relatively late finding. It consists of hypertension, bradycardia, and hypopnea. Hypertension occurs as the body attempts to maintain cerebral perfusion pressure (CPP). CPP can be calculated by subtracting the mean arterial pressure (MAP) from ICP (CPP = MAP - ICP). Because CPP is interdependent on MAP, an acute fall in blood pressure in patients with increased ICPplaces thematriskforcerebralhypoperfusion and long-termneurologic damage. Hypertension associated with increased ICP causes a compensatory bradycardia.Decreasedrespiratoryrateisalatefinding,signalingimpending herniation and is secondary to compression of brainstem respiratory centers from the increased pressure. Ideally, increased ICP should be identified and treatment started before these findings arise (Table 215.2).

Evacuation of a fluid (CSF or blood) collection or mass removal are the surgical interventions for increased ICP. Medical management of increased ICP includes elevation of the head of the bed, osmotic diuretics, hypertonic saline, hyperventilation, sedation, and hypothermia. Varying amounts of evidence exist for the effectiveness of these interventions in decreasing ICP. Elevatingtheheadofthebedto30degreesisoneofthesimplestinterventions for patients with suspected increased ICP. It improves venous outflow from the brain and can be an effective measure at preventing increased ICP from escalating.

Table 215.1 Causes of Increased Intracranial Pressure
Brain parenchyma
Space-occupying lesion
• Epidural or subdural hematoma
• Mass
• Abscess
Cerebral edema
• Infection (meningitis/encephalitis)
• Toxin induced encephalopathy (lead, liver failure, Reye syndrome)
• Hypertensive encephalopathy
CSF
Hydrocephalus
• CSF Overproduction
• Decreased CSF absorption
• Blockage of CSF flow (aqueductal stenosis)
Blood
Head trauma
Subarachnoid hemorrhage
Venous sinus thrombosis
Miscellaneous
Pseudotumor cerebri


CSF, cerebrospinal fluid.

Table 215.2 Management Guidelines for Increased Intracranial Pressure
First-Line Therapy
• Sedation, analgesia, paralytics
• CSF drainage if ventriculostomy present
• Hyperosmotic therapy (mannitol of hypertonic saline)
• Mild hyperventilation (PaCO2 30–35 mm Hg)
Second-Line Therapy
• Barbiturate coma
• Hypothermia
• Aggressive hyperventilation (PaCO2 <30 mm Hg)


CSF, cerebrospinal fluid; PaCO2, partial pressure of arterial carbon dioxide.

Mannitol is the most thoroughly studied medication used to induce an osmotic diuresis in patients with increased ICP. Doses range from 0.25 to 1 g/kg and should be given as a bolus infusion. Mannitol is a large sugar that doesnotcrosstheblood–brainbarrier.Thisallowsittoexertanosmoticeffect on brain parenchyma, effectively decreasing the volume of the intracranial space,whichlowersICP.Mannitolalsoincreasesintravascularvolume,which improves cerebral blood flow and perfusion. If autoregulation is maintained within the brain, the improved oxygenation can lead to vasoconstriction in certain areas, which would also decrease ICP. One side effect of mannitol therapy is renal failure when serum osmolarity is >320 mOsm/L. If this problem arises, hypertonic (3%) saline can provide similar effects and can increase serum osmolarity to 360 mOsm/L without a concomitant risk of renal failure.

HyperventilationisacontroversialinterventionforincreasedICP.Cerebral blood flow (CBF) is exquisitely sensitive to changes in oxygenation and ventilation, with hypoxia and hypercapnia causing increased CBF and hypocapnia decreasing CBF. Intentionally inducing hypocapnia by hyperventilating a patient with increased ICP can lead to cerebral hypoperfusion. Even mild hypocapnia (partial pressure of arterial carbon dioxide [PaCO2] of 32–35 mm Hg) leads to hypoxia and generation of lactic acid, leading to possible neurologic damage. CBF decreases in the first 24 hours following head trauma and gradually improves over the next 3 to 4 days. Therefore, aggressive hyperventilation is not generally used in the treatment course to minimize additional risk of neurologic damage, but mild-to-moderate hyperventilation may be effective particularly for refractory ICP problems.

Two other therapeutic options may be tried if ICP is not lowered by hyperosmolarity and hyperventilation: barbiturate coma and hypothermia. Because of decreased cerebral metabolism, cerebral oxygenation requirements are lower for patients when they are in barbiturate coma. Pentobarbital is the mostfrequentlyusedbarbiturateusedtoinducecoma.Thesepatientsshould have continuous electroencephalograph monitoring to ensure adequate suppression of brain activity. Mechanical ventilation and pressor support will likely be needed in these patients. Hypothermia is another strategy aimed at decreasing cerebral metabolism and subsequently decreasing CBF.

Steroids are commonly used to treat cerebral edema in patients with brain tumors. However, there is no evidence to support the use of steroids in increased ICP, unless patients have a documented decreased cortisol level.

Suggested Readings

Allen CH, Ward JD. An evidence-based approach to management of increased intracranial pressure. Crit Care Clin. 1998;14:485–495.
Jankowitz BT, Adelson PD. Pediatric traumatic brain injury: past, present and future. Dev Neurosci. 2006;28(4-5):264–275.
Soustiel JF, Mahamid E, Chistyakov A, et al. Comparison of moderate hyperventilation and mannitol for control of intracranial pressure control in patients with severe traumatic brain injury–astudyofcerebralbloodflowandmetabolism.ActaNeurochir(Wien).2006;148:845– 851.
Tasker RC. Neurological critical care. Curr Opin Pediatr. 2000;12:222–226.

>

Book Source Details

  • Book Title: Avoiding Common Pediatric Errors
  • Author(s): Anthony D Slonim MD, DrPH; Lisa Marcucci MD
  • Year of Publication: 2008
  • Copyright Details: Avoiding Common Pediatric Errors, Copyright © 2008 Lippincott Williams & Wilkins.

Other Book Chapters Related to Increased intracranial pressure

Read excerpts from these other book chapters related to Increased intracranial pressure:

Medical Books Excerpts
 

Copyright Details: Avoiding Common Pediatric Errors, Copyright © 2008 Williams & Wilkins.

More About Causes of Increased intracranial pressure




More About This Book:
Title: Avoiding Common Pediatric Errors
Authors: Anthony D Slonim MD, DrPH; Lisa Marcucci MD
Publisher: Lippincott Williams & Wilkins
Copyright: 2008
ISBN: 0-7817-7489-6

 » Next page: Medications causing Increased intracranial pressure

Rate This Website

What do you think about the features of this website? Take our user survey and have your say:

Website User Survey

Medical Tools & Articles:

Next articles:

Tools & Services:

Medical Articles:

Forums & Message Boards

 
HONcode We subscribe to the HONcode principles

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise